L-DOPA Induced Dyskinesia Regulated By DNA Methylation

The drug levodopa can significantly improve Parkinson’s disease symptoms, but within five years one half of the patients using L-DOPA develop an irreversible condition; involuntary repetitive, rapid and jerky movements. […]

What Is Spinocerebellar Ataxia Type 1

Spinocerebellar ataxia type 1 (SCA1) is a condition characterized by progressive problems with movement. People with this condition, also known as olivopontocerebellar atrophy I, initially experience problems with coordination and […]

Cannabinoids Abolish Amyloid Beta From Brain Cells

Preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease, has been found by […]

NMNAT2 Enzyme May Protect Against Neurodegeneration

An enzyme known as NMNAT2 may help protect against the debilitating effects of certain degenerative brain diseases, including Alzheimer’s, research led by biomedical researchers at Indiana University has found. Many […]